Bladder cancer

Molecular diagnostics in the era of targeted therapies for mUCa

Last updated: 10.05.2024

Solve cases and receive feedback

Case 1 - Platinum- and IO-refractory mUCa, molecular alterations

Case 2 - MIBC progressing to mUCa, sample types

Case 3 - MIBC progressing to mUCa, molecular tests

Case 4 - Platinum- and IO-refractory mUCa, FGFR wild type

Case 5 - Platinum- and IO-refractory mUCa, FGFR alteration

Case 6 - Platinum- and IO-refractory mUCa, molecular testing

Follow a course and earn CME credits

Earn CME credits by running a case series and completing an assessment. Many topics available for various disease areas. And all for free!

Start a course